Remove Doctors Remove Pharmacy Remove Sales
article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

pharmaphorum

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. So, suddenly, you’re unable to get the medicine you need and have been prescribed by a doctor.

Pharmacy 138
article thumbnail

Digital health player UpHealth swells with three-way merger

pharmaphorum

The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients. The largest by far was the $18.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTC launches probe into pharmacy benefit management sector

pharmaphorum

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). The post FTC launches probe into pharmacy benefit management sector appeared first on.

article thumbnail

NEW FEXOFENADINE over the counter – Allevia tablets

Druggist

The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. When to speak to a pharmacist or a doctor before taking Allevia tablets? Until now, fexofenadine was a prescription-only medication. cetirizine.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In the case of Novartis’ antihypertensive drug Exforge (amlodipine and valsartan), retail pharmacies including CVS, Walgreens, and two other plaintiff groups accused Novartis and Endo International’s Par Pharmaceutical unit of forming an illegal “reverse payment” agreement to delay the launch of less expensive generic versions of the drug.

Doctors 242
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

According to the figures compiled in the third quarter of last year, pharma brands were projected to spend around $10 billion in 2020 on digital advertising aimed at all groups including doctors, a compound annual growth rate of more than 13% since 2014. They are going to share content ahead of meetings.

Marketing 100
article thumbnail

Teva shares slide as it faces illegal kickback charges from US government

pharmaphorum

Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer). The allegation is that Teva’s subsidiaries Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.